Could a new combo pill boost Alzheimer's care?
Symptom relief
Not yet recruiting
This study tests whether adding an experimental drug (X/T+X-EC) to the standard Alzheimer's medication lecanemab is safe and tolerable. About 60 adults with Alzheimer's will receive either the new drug or a placebo for 24 weeks. The main goal is to check for side effects, while a…
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Symptom relief
Last updated May 26, 2026 10:27 UTC